KIDVERITAS
DEAD

Serial Number

97145993

Owner

Renalytix AI, Inc.

Attorney

Susan Piascik Christoff

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

KIDVERITAS Trademark

Serial Number: 97145993

KIDVERITAS is a trademark filed by Renalytix AI, Inc. on November 29, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Renalytix AI, Inc. (23 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

November 29, 2021

Registration Date

Not Registered

Published for Opposition

December 20, 2022

Goods & Services

Providing online newsletters in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, and the use of artificial intelligence for medical analysis; entertainment, information, and education services, namely, providing podcasts in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, and the use of artificial intelligence for medical analysis; video production; arranging and conducting of conferences, symposia, and educational special events in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, and the use of artificial intelligence for medical analysis; Educational services, namely, conducting informal on-line programs in the fields of health and medical information, kidney health, kidney disease, kidney disease treatments, and the use of artificial intelligence for medical analysis, and printable materials distributed therewith

Health care cost review services, namely, evaluating, identifying, and recording health care outcomes, patient satisfaction, health care management, and health care delivery efficiency for value-based medical cost management

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing information in the field of health and medical information, healthcare, kidney health, kidney disease, kidney disease treatments, value-based care, health care navigation, and the use of artificial intelligence for medical analysis; Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease; Providing on-line healthcare and medical information via medical reference databases to consumers, patients, caregivers, providers, administrators and other participants in the healthcare industry; Providing general medical information to consumers, patients, caregivers, providers, administrators and other participants in the health care industry via an on-line computer network in the fields of fields of health and medical information, kidney health, kidney disease, kidney disease treatments, and the use of artificial intelligence for patient care diagnostic medical analysis

Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney diseases and kidney health; medical research services; research and development services in the field of antibodies; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; testing, analysis, and evaluation of the goods and services of others to determine conformity with certification standards

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 18, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 18, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 14, 2023 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Feb 6, 2023 CHPB
ASSIGNED TO PETITION STAFF
Jan 30, 2023 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 17, 2023 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 10, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2022 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Apr 19, 2022 CEPE
ASSIGNED TO LIE
Apr 15, 2022 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 15, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 15, 2022 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 15, 2022 CPEA
ASSIGNED TO EXAMINER
Mar 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2021 NWOS
NEW APPLICATION ENTERED
Dec 2, 2021 NWAP